MYL9 and cancer: Treating activated myofibroblasts with VP reduced expression of Col1A1, Myl9 and Ctgf, a YAP-1 target gene in fibroblasts and cancer cell lines28, and an indicator of HSC activation29, 30 (Fig. 3k).